Results 241 to 247 of about 5,703,192 (247)

Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: Single center experience

Catheterization and Cardiovascular Interventions, 2018
Cem Coteli, Anıl Arat, Kudret Aytemir
exaly  

Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

Journal of the American College of Cardiology, 1999
Sherif F Nagueh, Nasser M Lakkis, N M Lakkis   +2 more
exaly  

Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy

Journal of the American College of Cardiology, 2001
Sherif F Nagueh, Ramiro Flores-Ramírez, Nasser M Lakkis   +2 more
exaly  

Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy

Journal of Thoracic and Cardiovascular Surgery
Mackram F Eleid, Hao Cui, Joseph A Dearani   +2 more
exaly  

Associations between procedural volume, costs, and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy in US hospitals

Journal of Medical Economics
Andrew Wang, Zhun Cao
exaly  

Sex-Associated Differences in Clinical Outcomes After Septal Reduction Therapies in Hypertrophic Cardiomyopathy

Mayo Clinic Proceedings
Garima Arora, Christopher Semsarian, Akhil Pampana   +2 more
exaly  

Back to square one: the role of septal reduction therapy in the era of Mavacamten

Cardiovascular revascularization medicine. Interesting cases
Ryan Kabir, Toby Rogers, Ryan Wallace
exaly